The Tisch Cancer Institute at Mount Sinai has been awarded a $1.9 million grant by NCI for a study that will explore the mechanisms that enable tumor cells to spread from their original site but remain dormant for some time before becoming metastatic and threatening the lives of patients.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
